Last reviewed · How we verify

NCT05889975

The Efficacy of Different Adjunctive Plaque Control Modalities in Orthodontic Patients

Completed Phase 3 Last updated 8 July 2024
What this trial tests

Phase 3 trial testing interdental brush in Gingivitis in 60 participants. Completed in 5 June 2023.

Timeline
9 January 2023
Primary endpoint
8 April 2023
5 June 2023

Quick facts

Lead sponsorUniversity of Baghdad
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment60
Start date9 January 2023
Primary completion8 April 2023
Estimated completion5 June 2023
Sites1 location across Iraq

Drugs / interventions tested

Conditions studied

Sponsor

University of Baghdad

Who can join

Adults 14 to 25, any sex, with Gingivitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bacterial plaque is the primary etiological factor for periodontal disease ranging from mild gingival inflammation to severe periodontitis.The fixed appliance can alter the microbial composition of the oral environment.Patients who wear fixed braces must perform optimum oral hygiene techniques .using a regular toothbrush alone for plaque removal is important but it is not adequate;therefore,an Adjunctive Plaque Control such as inter dental brush ,single tufted brush and water irrigator are helpful.the objective of this study To compare the efficacy of water irrigator ,single tufted and interdental brush in reducing gingival inflammation and plaque accumulation and To determine the profile of the salivary (MIF) at base line visit and after 4 weeks of the study .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gingivitis

Currently open trials in the same condition.

Other University of Baghdad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05889975.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing